The next chapter in MOF pillaring strategies: trigonal heterofunctional ligands to access targeted high-connected three dimensional nets, isoreticular platforms JF Eubank, L Wojtas, MR Hight, T Bousquet, VC Kravtsov, M Eddaoudi Journal of the American Chemical Society 133 (44), 17532-17535, 2011 | 178 | 2011 |
On demand: the singular rht net, an ideal blueprint for the construction of a metal–organic framework (MOF) platform JF Eubank, F Nouar, R Luebke, AJ Cairns, L Wojtas, M Alkordi, ... Angewandte Chemie-International Edition 51 (40), 10099, 2012 | 145 | 2012 |
Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2, 5-dimethoxybenzyl)-2-phenoxyaniline JR Buck, ET McKinley, MR Hight, A Fu, D Tang, RA Smith, MN Tantawy, ... Journal of Nuclear Medicine 52 (1), 107-114, 2011 | 73 | 2011 |
Quantitative preclinical imaging of TSPO expression in glioma using N, N-diethyl-2-(2-(4-(2-18F-fluoroethoxy) phenyl)-5, 7-dimethylpyrazolo [1, 5-a] pyrimidin-3-yl) acetamide D Tang, MR Hight, ET McKinley, A Fu, JR Buck, RA Smith, MN Tantawy, ... Journal of Nuclear Medicine 53 (2), 287-294, 2012 | 72 | 2012 |
Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer M Hassanein, MR Hight, JR Buck, MN Tantawy, ML Nickels, ... Molecular imaging and biology 18, 18-23, 2016 | 56 | 2016 |
Synthesis and structure–activity relationships of 5, 6, 7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging D Tang, ET McKinley, MR Hight, MI Uddin, JM Harp, A Fu, ML Nickels, ... Journal of medicinal chemistry 56 (8), 3429-3433, 2013 | 55 | 2013 |
Mutant KRAS exosomes alter the metabolic state of recipient colonic epithelial cells Q Zhang, DK Jeppesen, JN Higginbotham, MD Beckler, EJ Poulin, ... Cellular and Molecular Gastroenterology and Hepatology 5 (4), 627-629. e6, 2018 | 39 | 2018 |
A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells MR Hight, YY Cheung, ML Nickels, ES Dawson, P Zhao, S Saleh, ... Clinical Cancer Research 20 (8), 2126-2135, 2014 | 37 | 2014 |
Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAFV600E In Vivo ML Schulte, MR Hight, GD Ayers, Q Liu, Y Shyr, MK Washington, ... Molecular imaging and biology 19, 421-428, 2017 | 26 | 2017 |
Multispectral fluorescence imaging to assess pH in biological specimens MR Hight, DD Nolting, ET McKinley, AD Lander, SK Wyatt, M Gonyea, ... Journal of biomedical optics 16 (1), 016007-016007-7, 2011 | 23 | 2011 |
Microwave-assisted organic synthesis of a high-affinity pyrazolo-pyrimidinyl TSPO ligand D Tang, JR Buck, MR Hight, HC Manning Tetrahedron letters 51 (35), 4595-4598, 2010 | 23 | 2010 |
TSPO-targeted PET and optical probes for the detection and localization of premalignant and malignant pancreatic lesions AS Cohen, J Li, MR Hight, E McKinley, A Fu, A Payne, Y Liu, D Zhang, ... Clinical Cancer Research 26 (22), 5914-5925, 2020 | 12 | 2020 |
N-[18F]-Fluoroacetylcrizotinib: A potentially potent and selective PET tracer for molecular imaging of non-small cell lung cancer JR Buck, S Saleh, T Claus, C Lovly, MR Hight, ML Nickels, MN Tantawy, ... Bioorganic & medicinal chemistry letters 30 (16), 127257, 2020 | 4 | 2020 |
Compound, composition, and method for detecting caspase activity and/or apoptosis HC Manning, MR Hight US Patent 10,294,271, 2019 | 1 | 2019 |
Glutamine PET to Predict Response to Dual Pharmacological Inhibition of BRAFV600E and PI3K/mTOR Pathway Activity in vivo. M Schulte, M Hight, G Ayers, F Revetta, MK Washington, M Nickels, ... Journal of Nuclear Medicine 57 (supplement 2), 447-447, 2016 | | 2016 |
CCDC 1408290: Experimental Crystal Structure Determination: catena-[(mu-5-(pyridin-4-ylmethoxy) isophthalato)-copper unknown solvate] JF Eubank, L Wojtas, MR Hight, T Bousquet, VC Kravtsov, M Eddaoudi Cambridge Crystallographic Data Centre, 2015 | | 2015 |
PET imaging diagnostics of mitochondrial homeostasis in precision cancer medicine MR Hight | | 2014 |
Molecular imaging of glutaminolysis as a tool for evaluating therapeutic response in preclinical models of colorectal cancer MR Hight, ML Schulte, S Saleh, GD Ayers, FL Revetta, MK Washington, ... Cancer Research 74 (19_Supplement), 2058-2058, 2014 | | 2014 |
CCDC 866715: Experimental Crystal Structure Determination: catena-((mu~ 12~-tris (4-(5'-ethynyl-1, 1': 3''. 1''-terphenyl-4, 4''-dicarboxylic acid) phenyl) amine)-tri-aqua-tri … JF Eubank, F Nouar, R Luebke, A Cairns, L Wojtas, M Al Kordi, ... Cambridge Crystallographic Data Centre, 2013 | | 2013 |
CCDC 866713: Experimental Crystal Structure Determination: catena-(bis (mu~ 12~-5, 5', 5''-(1, 3, 5-benzenetriyltris (methyleneoxy))-tris (1, 3-benzenedicarboxylato))-hexa-aqua … JF Eubank, F Nouar, R Luebke, A Cairns, L Wojtas, M Al Kordi, ... Cambridge Crystallographic Data Centre, 2013 | | 2013 |